Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells (Q47387344)

15 January 2018

reason for preferred rank

title

Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells (English)

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

1 April 2024

Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615377

1 April 2024

0 references

1 reference

chronic lymphocytic leukemia

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

1 April 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

1 April 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

1 April 2024

author name string

Garyfalia Tsakou

2

1 reference

15 January 2018

Frank Grünebach

3

1 reference

15 January 2018

Peter Brossart

5

1 reference

15 January 2018

Martin R. Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615377

1 April 2024

Susanne M. Schmidt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615377

1 April 2024

language of work or name

English

0 references

publication date

13 November 2003

1 reference

15 January 2018

full work available at URL

https://ashpublications.org/blood/article-pdf/103/5/1763/1695906/zh800504001763.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615377

http://ashpublications.org/blood/article-pdf/103/5/1763/1695906/zh800504001763.pdf

1 April 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

1 April 2024

1 reference

15 January 2018

volume

103

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

1763-1769

1 reference

15 January 2018

Chronic lymphocytic leukemia. A review of 745 cases and assessment of clinical staging

cites work

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Rituximab in chronic lymphocytic leukemia

1 April 2024

9

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies

1 April 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?

1 April 2024

14

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Allogenic bone marrow transplantation in chronic lymphocytic leukemia

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 April 2024

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 April 2024

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Abnormal association between invariant chain and HLA class II alpha and beta chains in chronic lymphocytic leukemia

1 April 2024

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Inhibition of T cell/B cell interaction by B-CLL cells

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy

1 April 2024

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Dendritic cells and the control of immunity

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Dendritic cells in cancer vaccines

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

1 April 2024

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines

1 April 2024

42

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

1 April 2024

43

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 April 2024

46

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 April 2024

47

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes

1 April 2024

49

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes

1 April 2024

50

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

1 April 2024

55

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis

1 April 2024

56

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins

1 April 2024

57

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy

1 April 2024

58

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-06-2097

1 April 2024

Identifiers

1 reference

15 January 2018

1 reference

15 January 2018